Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment

December 25, 2022 updated by: Uşak University

Clinical and Radiographic Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment

In our study, it was aimed to compare the long-term effectiveness of diode laser and low level laser therapy and primary tooth amputation treatments using calcium hydroxide (LLLT+CH) in primary second molars with deep dentinal caries. Ninety patients ( 42 Gırl, 48 Boy) aged 6-9 years with deep dentin caries in the mandibular second molar were included in the study. The patients were randomly selected according to the treatment to be applied and divided into two groups as the diode laser group (N=45) and the LLLT+CH group (N=45). The patients were called for control appointments at the 1st, 3rd, 6th and 12th months after the treatment, and both clinical and radiographic follow-ups were performed. Chi-square and Fisher's Exact tests were used to compare categorical variables according to groups in statistical analysis, and p<0.05 was considered significant. When the study results at the end of 12 months were evaluated, the diode laser group had a clinical success rate of 95.6%, and a success rate of 93.3% radiologically; The LLLT+CH group had a success rate of 97.7% clinically and 90.9% radiologically. There was no statistically significant difference between the success rates of the groups (p>0.05). According to the clinical and radiographic results of our study, it was determined that diode laser and LLLT+CH amputations showed similar success rates in primary second molars with deep dentin caries. It has been seen that both methods can be used safely in primary tooth amputations. It is thought that clinical and histological studies and studies examining the effectiveness of dental laser applications in primary tooth amputation treatment are needed.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Uşak, Turkey, 64200
        • Uşak University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 9 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Clinical Criteria

  • No systemic disease
  • Not allergic to the materials used
  • Children with scores of 1 and 2 according to the Frankel behavioral scale
  • Those who have erupted permanent first molars
  • The one in occlusion with the opposing tooth
  • Not having bad oral habits
  • No structural anomaly in the teeth
  • No spontaneous or nocturnal pain
  • No sensitivity to palpation or percussion
  • Abscess and fistula formation free
  • No pathological mobility
  • During treatment, pulp bleeding is controlled within 5 minutes.
  • With a crown that can be made of stainless steel crown (PÇK)

Radiographic Criteria

  • Having a deep dentin caries lesion very close to the pulp
  • No resorption in the bifurcation and periapical area
  • Periodontal space is healthy and there is no periapical region pathology
  • Absence of internal and external root resorption in roots
  • No calcified masses in the pulp
  • Teeth that did not exceed one-third of the physiological root resorption were included in the study.

Exclusion Criteria

-Children with a score of 1 and 4 on the Frankel Scale were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: diode laser pulpotomy
  • Diode laser (Solase-976 Dental Diode Laser)
  • With a wavelength of 980 nm and a frequency of 110 Hz
  • In pulse mode, working for 1 ms and stopping for 8 ms
  • With a power output of 1 W during each laser pulse from the 400 µm fiber optic tip
  • By touching the fiber optic tip to the remaining pulp tissue
  • for 3 seconds
  • With 3 J energy to each root pulp during the process
diode laser was applied during the pulpotomy procedure
Experimental: low level diode laser pulpotomy
  • Diode laser (Solase-976 Dental Diode Laser)
  • It has a wavelength of 980 nm and a frequency of 165 Hz.
  • In pulse mode by setting it to run for 2 ms and stop for 4 ms
  • At a power of 0.2 W during each laser pulse from a 400 µm fiber optic tip
  • Without the fiber optic tip touching the remaining pulp tissue
  • for 10 seconds
  • With 2 J Energy to each root pulp
Low-dose diode laser was applied during the pulpotomy procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
radiographic success of treatments at the end of 12 months
Time Frame: 12 months
teeth without any signs of pathological internal and external root resorption, enlargement of the periodontal space, and radiolucency in the periapical and furcation region
12 months
clinical success of treatments at the end of 12 months
Time Frame: 12 months
teeth without any of the signs of spontaneous pain, tenderness on palpation and percussion, pathological mobility, sinus tract or gingival abscess form, lymphodanepathy in the relevant region
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tugba YIGIT, Uşak University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

May 30, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

December 16, 2022

First Submitted That Met QC Criteria

December 25, 2022

First Posted (Estimate)

January 11, 2023

Study Record Updates

Last Update Posted (Estimate)

January 11, 2023

Last Update Submitted That Met QC Criteria

December 25, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UsakU10

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulpotomy

Clinical Trials on diode lazer

Subscribe